MedPath

Clinical study of autologous noncultured epidermal cell transplantation for leukoderma treatment

Phase 1
Conditions
Stable vitiligo
Registration Number
JPRN-UMIN000037612
Lead Sponsor
Osaka University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
5
Inclusion Criteria

Not provided

Exclusion Criteria

Apparently unstable patients defined as new areas of depigmentation or enlarging areas of depigmentation within the last 12 months. Patients with treatment of steroid, active vitamin D3, calcineurin inhibitor and light radiation therapy within the 4 weeks befor registration. History of keloidal scars and presence of Koebner's phenomenon Patients with allergies to antibiotics and local anaesthetics Patients with tape rash Pregnant women, lactating women and patients who deaire pregnancy during clinical studies. Positive serology of Hepatitis B and C, HIV, HTLV-1 Patients who are participating in other clinical studies including interventions or non-interventions such as observation studies. Investigators judge the patiens should not paticipate in the study for any reason

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath